Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled unfractionated heparin dose-ranging safety trial in mechanically ventilated adults without acute lung injury
NL-OMON27158Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of heparin in acute lung injury (ALI) (4 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Area under the curve of serial anti-Xa measurements in plasma. Planned start Feb 2007; status: not yet recruiting.
02
Drugs
heparin
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NL-OMON27158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27158.